FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 330:794-795 March 17, 1994 Number 11 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Vega, W. A. Related Article by Sibai, B. M.

To the Editor: In the report by Sibai et al. (Oct. 21 issue)¹ on the use of low-dose aspirin to prevent preeclampsia, the overall perinatal mortality was similar in the aspirin and placebo groups (aspirin: 22 deaths among a total of 1545 fetuses, or 14.2 deaths per 1000 live births; placebo: 14 deaths among 1551 fetuses, or 9.0 deaths per 1000 live births), but the difference in the number of fetal deaths after 20 weeks' gestation was almost significant by chi-square analysis (17 deaths among 1570 fetuses vs. 7 among 1565, respectively; P = 0.06). As Zuspan and Samuels point . . . [Full Text of this Article]

References

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.